URBN
62
-5
TRV
52
10
MET
60
-3
MSI
55
3
VIX
19
-5
DHI
49
-9
FOX
30
-3
GRMN
64
2
TAP
41
-2
ES
36
3
AZO
48
-10
CF
42
-3
ABT
50
-3
PNW
46
-2
INTC
47
4
ROST
70
-3
RCL
73
-4
CFG
40
-2
PDCO
75
17
GPC
38
-5
URBN
62
-5
TRV
52
10
MET
60
-3
MSI
55
3
VIX
19
-5
DHI
49
-9
FOX
30
-3
GRMN
64
2
TAP
41
-2
ES
36
3
AZO
48
-10
CF
42
-3
ABT
50
-3
PNW
46
-2
INTC
47
4
ROST
70
-3
RCL
73
-4
CFG
40
-2
PDCO
75
17
GPC
38
-5
Financhill
Back

PIMCO Corporate & Income Opportunity Fds Vs. Viking Therapeutics Industry Stock Comparison

Buy
62

PTY
PIMCO Corporate & Income Opportunity Fds

Last Price:
14.30
Seasonality Move:
-0.96%
Sell
44

VKTX
Viking Therapeutics

Last Price:
52.96
Seasonality Move:
1.76%
Buy
62
PIMCO Corporate & Income Opportunity Fds (PTY) is a Buy

Is PIMCO Corporate & Income Opportunity Fds a Buy, Sell or Hold?

  • The current PIMCO Corporate & Income Opportunity Fds [PTY] share price is $14.31. The Score for PTY is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • PTY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $52.96. The Score for VKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PTY Stock Price Chart

What is PIMCO Corporate & Income Opportunity Fds's stock price today?

  • The PIMCO Corporate & Income Opportunity Fds share price today is $14.31
    The current trend is relatively stagnant and PTY is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $52.96
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight buying pressure.

PTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 49.94 Sell
Chaikin Money Flow: 215226 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.9 Sell
Relative Strength Index (14 RSI): 43.41 Sell
Chaikin Money Flow: 113403 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (50.34 - 60.74) Sell
Bollinger Bands (100): (47.23 - 79.29) Sell

PTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.25 Buy
20-day SMA: 14.37 Sell
50-day SMA: 14.25 Buy
200-day SMA: 13.83 Buy
8-day EMA: 14.28 Buy
20-day EMA: 14.31 Buy
50-day EMA: 14.3 Buy
200-day EMA: 14.01 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.6 Buy
20-day SMA: 53.66 Sell
50-day SMA: 63.66 Sell
200-day SMA: 39.18 Buy
8-day EMA: 51.13 Buy
20-day EMA: 54.21 Sell
50-day EMA: 59.37 Sell
200-day EMA: 45.7 Buy

PIMCO Corporate & Income Opportunity Fds Earnings Growth & PTY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.

PIMCO Corporate & Income Opportunity Fds Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):